This move is archived. Current quotes and coverage live on the stock page.
Follow TELY
TelyRx Holdings Inc. is making waves on the TSX with a notable surge in its stock price.
TelyRx Holdings Inc. (TELY.TO) is rising today, showcasing a robust performance with a 7.25% increase in its stock price. Investors are taking notice as the company continues to innovate and expand its offerings in the healthcare sector.
Advertisement
TelyRx Holdings Inc.
TELY.TO
TELY.TO
TelyRx Holdings Inc.
WealthAwesomeMarket cap
$69.14M
52W high
$4.25
52W low
$2.00
1W change
+10.64%
Analyst Price Targets
Based on analyst covering TELY · as of Sep 17, 2026
Wall Street analysts forecast TELY stock price to rise 130.8% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$6.00
+130.8% Upside
Current Price
C$2.60
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on TELY's historical volatility
30-Day Vol
60.6%
Annualized
90-Day Vol
88.9%
Annualized
Trend (90d)
+25.0%
Annualized drift
90d Mean
C$2.84
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$2.68 | C$2.17 – C$3.30 |
| 60 trading days | C$2.76 | C$2.05 – C$3.71 |
| 90 trading days | C$2.84 | C$1.98 – C$4.08 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: The recent uptick in TelyRx's stock reflects investor confidence, driven by the company's strategic initiatives and financial growth.
TelyRx Holdings Inc. Stock Jumps 7.25%
The stock closed at CA$2.73, reflecting a significant rise that may indicate growing investor interest.
Bull case
TelyRx is focused on improving patient access to healthcare with its new brand platform. This commitment positions the company for future growth, which could attract more investors and help it gain market share.
Bear case
Despite the positive movement, TelyRx still faces challenges. The company reported a net loss in its latest financial results, raising concerns about its long-term profitability.
TelyRx's Strategic Moves
Advertisement
TelyRx has recently launched a new brand and digital experience aimed at simplifying access to healthcare. This initiative is designed to significantly expand its medication offerings, potentially boosting its market presence and attracting new customers.
Financial Performance Insights
In its latest financial report, TelyRx demonstrated a revenue increase to $19.4 million in Q1 2026, up from $14.3 million in the previous quarter. However, the company still reported a net loss of $4.7 million, highlighting the need for sustained growth to achieve profitability.
Market Reaction and Future Outlook
The market's positive reaction to TelyRx's stock surge indicates growing confidence among investors. As the company continues to roll out its new initiatives and improve its financial standing, it may see further stock price appreciation in the future. For more details on TelyRx's performance, visit the Wealth Awesome stock page.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
